Evidence map›Paper›PMID 34759371›Full record

ArticleCellular & molecular immunology2021

CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis.

JieJie Geng, Ruo Chen, Feng-Fan Yang, Peng Lin, Yu-Meng Zhu, Xianghui Fu, Ke Wang, Zhuan Feng, Jiao Wu, Hai Zhang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. T Lymphocytes as Targets for SARS-CoV-2.Biochemistry. Biokhimiia · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

JieJie Geng *Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China.
Ruo Chen *Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China.
Feng-Fan Yang *Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China.
Peng Lin *National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China.
Yu-Meng Zhu *Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China.
Xianghui FuDepartment of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China.
Ke WangNational Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China.
Zhuan FengNational Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China.
Jiao WuNational Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China.
Hai ZhangNational Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China.
Qi-Jing LiDepartment of Immunology, Duke University Medical Center, Durham, NC, USA. qi-jing.li@duke.edu.ORCID http://orcid.org/0000-0002-0542-9784
Zhi-Nan ChenNational Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, P. R. China. znchen@fmmu.edu.cn.ORCID http://orcid.org/0000-0001-5512-4623
Ping ZhuDepartment of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, P. R. China. zhuping@fmmu.edu.cn.
Air Force Medical University · CNXijing Hospital · CNDuke University · US

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31800756
6 · The paper itself

Abstract

Regulatory T cell (Treg) stability is necessary for the proper control of immune activity and tissue homeostasis. However, it remains unclear whether Treg stability must be continually reinforced or is established during development under physiological conditions. Foxp3 has been characterized as a central mediator of the genetic program that governs Treg stability. Here, we demonstrate that to maintain Foxp3 protein expression, Tregs require cell-to-cell contact, which is mediated by the CD147-CD98 interaction. As Tregs are produced, CD147, which is expressed on their surface, is stimulated by CD98, which is widely expressed in the physiological environment. As a result, CD147's intracellular domain binds to CDK2 and retains it near the membrane, leading to Foxp3 dephosphorylation and the prevention of Foxp3 degradation. In addition, the optimal distribution of Foxp3+ Tregs under both pathological and physiological conditions depends on CD98 expression. Thus, our study provides direct evidence that Foxp3-dependent Treg stability is reinforced in the periphery by the interaction between CD147 and CD98 in the surrounding environment. More importantly, Tregs with high CD147 expression effectively inhibit inflammatory responses and maintain Foxp3 stability, which has guiding significance for the application of Tregs in immunotherapy.

Indexed as

Signal TransductionT-Lymphocytes, RegulatoryAnimalsBasiginForkhead Transcription FactorsFusion Regulatory Protein-1HomeostasisHumansImmunotherapyMiceBasiginForkhead Transcription FactorsFOXP3 protein, humanFoxp3 protein, mouseFusion Regulatory Protein-1CD147CD98CDK2Immune therapyStabilityTreg

Identifiers

PMID34759371
PMCPMC8632965
OpenAlexW3211499550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.